Cargando…
Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?
In its severest forms, decompression sickness (DCS) may extend systemically and/or induce severe neurological deficits, including paralysis or even death. It seems that the sterile and ischemic inflammatory phenomena are consecutive to the reaction of the bubbles with the organism and that the blood...
Autores principales: | Lambrechts, Kate, de Maistre, Sébastien, Abraini, Jacques H., Blatteau, Jean-Eric, Risso, Jean-Jacques, Vallée, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050390/ https://www.ncbi.nlm.nih.gov/pubmed/30050468 http://dx.doi.org/10.3389/fphys.2018.00906 |
Ejemplares similares
-
Fluoxetine Protection in Decompression Sickness in Mice is Enhanced by Blocking TREK-1 Potassium Channel with the “spadin” Antidepressant
por: Vallée, Nicolas, et al.
Publicado: (2016) -
Thirty-five Day Fluoxetine Treatment Limits Sensory-Motor Deficit and Biochemical Disorders in a Rat Model of Decompression Sickness
por: Cosnard, Caroline, et al.
Publicado: (2017) -
Protective Effects of Fluoxetine on Decompression Sickness in Mice
por: Blatteau, Jean-Eric, et al.
Publicado: (2012) -
Xenon Blocks Neuronal Injury Associated with Decompression
por: Blatteau, Jean-Eric, et al.
Publicado: (2015) -
Colonic Fermentation Promotes Decompression sickness in Rats
por: de Maistre, Sébastien, et al.
Publicado: (2016)